[1]
“Search for SARS-CoV-2 Inhibitors. Is it still needed?Molecular Docking Study of Teicoplanin Derivatives and Vancomycin against SARS-CoV-2 Mpro”, Valensi, vol. 11, no. 1, pp. 60–68, May 2025, doi: 10.15408/jkv.v11i1.44709.